IQV
IQVIA Holdings Inc · NYSE
- Sector Health Services
- Industry Services to the Health Industry
- Website iqvia.com
- Employees(FY) 87000
- ISIN US46266C1053
Performance
+0.7%
1W
-7.31%
1M
-15.64%
3M
-7.31%
6M
-12.18%
YTD
-6.06%
1Y
Profile
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.
Technical Analysis of IQV 2024-12-10
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-10 07:00
Is IQVIA Holdings Inc.'s (NYSE:IQV) ROE Of 20% Impressive?(Simply Wall St.)
- 2024-12-06 09:00
- 2024-12-04 09:19
- 2024-12-03 00:41
Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China(The Wall Street Journal)
- 2024-12-02 07:58
- 2024-12-02 06:53
- 2024-12-01 07:00
- 2024-11-28 12:05
- 2024-11-27 09:00
- 2024-11-26 07:10
- 2024-11-25 05:56
- 2024-11-25 05:56
- 2024-11-23 21:00
A 12-Year-Old’s Journey Into the World of Ozempic(The Wall Street Journal)
- 2024-11-19 06:44
- 2024-11-06 16:15
- 2024-11-06 07:53
Argus Cuts Price Target on IQVIA to $260 From $280(MT Newswires)
- 2024-11-06 06:56
Analyst Report: IQVIA Holdings Inc(Argus Research)
- 2024-11-06 06:41
Market Digest: MAR, PGR, SHW, TROW, IQV, TWLO, NXPI(Argus Research)
- 2024-11-06 03:15
- 2024-11-05 07:11
- 2024-11-05 07:01
- 2024-11-04 09:15
- 2024-11-04 07:56
Weekly Stock List(Argus Research)
- 2024-11-01 14:27
Analyst Report: IQVIA Holdings Inc.(Morningstar Research)
- 2024-11-01 10:15
- 2024-11-01 09:27
- 2024-11-01 09:27
- 2024-11-01 09:27
BTIG Adjusts Price Target on IQVIA to $260 From $290(MT Newswires)
- 2024-11-01 09:26
Baird Adjusts Price Target on IQVIA to $223 From $256(MT Newswires)
- 2024-11-01 09:26
Barclays Adjusts Price Target on IQVIA to $255 From $260(MT Newswires)
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.